Lexaria Bioscience Corp. Quarterly report pursuant to Section 13 or 15(d)

Capital Stock (Narrative) (Details)	3 Months Ended
Capital Stock (Narrative) (Details)	Nov. 30, 2015 USD ($) $ / shares shares
Capital Stock 1	100,000
Capital Stock 2 \| $ / shares	$ 0.19
Capital Stock 3	39,952,984
Capital Stock 4	6,936,533
Capital Stock 5 \| $	$ 36,000
Capital Stock 6	200,000
Capital Stock 7 \| $	$ 0.18
Capital Stock 8 \| $	$ 36,000